Point-of-Care Partners | Proprietary and Confidential

RTPBC Activities Underway

Anthony Schueth, MSCEO & Managing Partner Point-of-Care Partners

2Point-of-Care Partners | Proprietary and Confidential

1. The merger of RxHub and Surescripts was a major catalyst in connecting patient identities with a specific formulary 2. NCPDP developed a standard format in which PBMS/payers should send formulary data to EHRs 3. Government regulations helped to push along mandatory use of electronic formulary data by physician practices4. ONC NPRM released in Feb 2014 was the catalyst for NCPDP efforts around RTBI and subsequent demonstration projects.

HIPAA Electronic

Transaction Final Rule

Mandated use of 270/271

eligibility inquiry/response

NCPDP F&B V 3.0

NCPDP Formulary and

Benefit v3.0 adopted

Creation of RxHub and Availability

of Electronic Formulary

RxHub/Surescripts Merger*

Merger of RxHub and Surescripts

Announced

NCPDP F&B V 1.0

NCPDP Formulary and

Benefit v1.0 adopted

CMS MU Stage 2

Final Rule

Requires at least 50% of

all permissible

prescriptions are queried

for drug formulary

MMA Deadline for

eRx Standards

Mandated payers to

support ePrescribing

using standards

July

2008

April

2009

March

2015

August

2012

Jan

2009

Formulary & Benefits/Real-Time Pharmacy Benefit Check (RTPBC)

Timeline

2

ONC NPRM

ONC Solicits comments on

NCPDP Telecom and Formulary

and Benefit Standard to support

expanded use cases such as

real-time benefit checks

Feb

2014

April 2015-

March 2018

RTBC Standards

Development & Pilots

Use cases, ONC

demonstration projects, first

RTBC systems and NCPDP

task group efforts

3Point-of-Care Partners | Proprietary and Confidential

Addresses Deficiencies in Current Formulary & Benefits

Challenges with accuracy of current Formulary & Benefit data led to a search for a better solution

• Formulary data is based on “Plan-” or “Group”-level; not patient specific

• Prior Authorization flag often missing or inaccurate

• Formulary tier/preferred level often not accurately displayed for HCP

• Issue is payer providing the data, not the standard

Formulary List ID

Coverage List ID

Co-pay List ID

Alternatives List ID

HCPPatient PBM/Processor

Formulary & Benefit

Data Plan MembershipAppointment

IntermediaryEligibility Request

First Name

Last Name

Gender

Birth date

ZIP code

Eligibility Response

4Point-of-Care Partners | Proprietary and Confidential

Formulary status

Coverage alerts

Channel options

Member Price

Alternative drugs

Tier or Preferred Level

Age & Quantity Limits, Prior Authorization (PA),

Step Therapy

Retail, Mail Order, Specialty

Member Copay and Cost Sharing Details

Preferred Formulary/ Lower Cost Options

RTPBC Provides Patient Specific Benefit Information

Real-Time Pharmacy Benefit Check (RTPBC) provides patient specific benefit information,

improving transparency and ensuring accurate display of tier/preferred information to health

care professionals (HCPs)

4

5Point-of-Care Partners | Proprietary and Confidential

Real-Time Pharmacy Benefit Check (RTPBC) – Why, How, When

• RTPBC solves data issues surrounding

formulary and benefit information including:

‒ Inaccurate display of preferred status and tier

level

‒ PA indicator missing or incorrect

‒ Benefit information at plan, not patient level

• RTPBC data pulled in real-time and direct from

payer

‒ Provides for more detailed benefit information at

patient level

• Formulary and Benefit files will not

be replaced

‒ Provides “directional” guidance during

the initial prescription decision

• On/Off Formulary -> Formulary Status

• Tier Level -> Copay Tier, Dollar or

Percentage Co-pay

• PA required

• Can help determine if

a RTPBC is even necessary

6Point-of-Care Partners | Proprietary and Confidential

Initiate RTPBCRequest

RTPBCResponseIntermediary

Prescription covered by benefit:

• Patient financial responsibility

PBM/Payer

Prescription not covered by benefits:

• Reason for Denial

• Alternatives

• Coverage Limits

RTPBC Response Data Elements

• PA required

• Step therapy

• Drug Utilization Review (DUR) alert

7Point-of-Care Partners | Proprietary and Confidential

With a Direct Connection, prescription benefit information comes directly from the

PBM/Payer to the EHR or RTPBC Service Provider. The EHR/RTBC Service Vendor needs

to connect directly to multiple PBMs

EHR/RTPBC

Service Vendor

PBM/Payer

RTPBC Transaction

Assumption: Vendor checks

patient eligibility to confirm where

to send RTPBC transaction

PBM/Payer

PBM/Payer

RTPBC Direct Connection

7

8Point-of-Care Partners | Proprietary and Confidential

Intermediaries already have connections to PBMs/Payers for

formulary information. The existing connections are used to send

and receive an RTPBC transaction

EHR/RTPBC

Service Vendor

PBM/Payer

RTPBC Transaction

PBM/Payer

PBM/Payer

RTPBC Intermediary Solutions

8

Intermediary

RTPBC Transaction

9Point-of-Care Partners | Proprietary and Confidential

Overall Spend and Volume Trends

Specialty medications continue to be a growing part of overall drug spend, yet Rx volume remains low. Due to the nature

of these medications, the “value” of a single transaction is high

Source: IQIVA Institute Report; Medicines Use and Spending in the U.S. A Review of 2016 and Outlook to 2021 – May 2017

0

50

100

150

200

250

300

350

400

450

2012 2013 2014 2015

0

20

40

60

80

100

120

140

160

180

Total Drug Spend by Category

Market Specialty Traditional

Percent of Total PrescriptionVolume by Category*

Specialty Rx2%

Traditional Rxs98%

*…but there are other transactions that are and could be facilitated to support the process

10Point-of-Care Partners | Proprietary and Confidential

2017 Specialty Spend Distribution

35%

21%

37%

6%

MEDICAL BENEFITDistribution by Site of Care

Physician Office Home Outpatient Hospital Other

61%

39%

BENEFIT DISTRIBUTION

Pharmacy Benefit Medical Benefit

Source: 14th Edition, EMD Serono Specialty Digest

11Point-of-Care Partners | Proprietary and Confidential

Specialty Medication Stakeholders

Medical Payers

Providers

IDNs

EHRs

Hub & Hub

Services

Pharmacy Benefit

Managers

Manufacturers

Pharmacies

Patient

12Point-of-Care Partners | Proprietary and Confidential

The Complexity of Specialty

Drug Dispensing

There is a significant

amount of complexity

involved with

dispensing specialty

medications and a

number of areas to

focus on in regards to

standards and moving

processes electronic

Prescription

Benefit Determination

Enrollment

Copay Assistance

Prior Auth

REMS

Dispense

Deliver

Med Adherence

13Point-of-Care Partners | Proprietary and Confidential

The Patient Burden

• Patient out-of-pocket costs vary widely

between medical and pharmacy benefit and

between dispensing sites

• The patient may not be aware of co-pay

assistance programs and may abandon

therapy if co-pay is too high, particularly if

the medication falls under the medical

benefit

• Patients are forced to be their own

advocates

• Employer benefit changes are particularly

challenging for patients and cause therapy

delays that negatively impact outcomes

9%

23%

27%

No

Deductible

Brands with

Deductible

Specialty Brands

with Deductible

Abandonment Rates for Branded Medicines

Almost 1 in 4 Prescriptions Are Abandoned By

Patients During Their Deductible Phase

Source: Amundsen Consulting (a division of QuintilesIMS) analysis for PhRMA; IMS FIA; Rx Benefit Design, 2015

14Point-of-Care Partners | Proprietary and Confidential

Addressing Barriers: Da Vinci Project Coverage Requirements

Discovery

• Providers need to easily discover which

payer covered services or devices have

– Specific documentation requirements or

guidance,

– Rules for determining need for specific

treatments/services

– Requirement for Prior Authorization (PA) or

other approvals

• FHIR based API enables providers to

discover payer-specific coverage

requirements in real-time

– Answer to discovery request

– A list of services, templates, documents, rules

– URL to retrieve specific items (e.g. template)

PROVIDER

PAYER

Order Procedure, Lab or Referral

Discover AnyRequirements

15Point-of-Care Partners | Proprietary and Confidential

Considerations, Drivers, Future

• Innovators/Early Adopters will help

determine the value and lessons

learned/best practices

• There are costs to both the payers/PBMs

and EHRs

• Formulary and Benefit (F&B) will not go

away with introduction of RTBC;

there’s debate but both are likely needed

• What will drive wide-spread adoption of

RTBC?

• Regulations

• Business model

16Point-of-Care Partners | Proprietary and Confidential

Questions?

Thank You!

Tony Schueth, MS CEO & Managing PartnerPoint-of-Care Partnerstonys@pocp.com